News About: Pharm. Industry
Illegal rebate activities in drug industry specified
The Ministry of Health and Welfare has clarified the definition of rebate activities and made more specific countermeasures against such practices through a fair trade agreement.
In an information session Monday, h...
More pharmaceutical firms keen on recruiting doctors
Influenced by the rapidly changing marketing environments here, more and more domestic pharmaceutical companies have rolled their sleeves to recruit physicians.
In particular, pharmaceutical companies are highly sp...
Choi tae-heung to head Janssen’s three branches in North Asia
Janssen headquarters has recently named Choi Tae-heung, incumbent president of its Korean unit Janssen Korea, as a head to take charge of its three branches in North Asia, such as Hong Kong, Taiwan and Korea.
Choi,...
Korea, US agree on delay linkage of drug approval and patent by 3 years
Korea and the United States have agreed to delay a system to suspend the approval process of a generic drug when the original developer files a complaint about patent violation against a generic maker that applies for...
Pharmaceutical industry supports trade deal
Korea's pharmaceutical sector is showing positive response to the free trade agreement (FTA) signed between Korea and the U.S. over the weekend.
The pharmaceutical industry expressed support for the pact, expecting...
Local drug makers urged to focus on research and development of new drugs
Domestic drug makers should pursue the knowledge-intensive industry based on research and development to survive in an era of the Korea-U.S. FTA, away from the labor-intensive industry centering on sales and marketing...
Shinpoong enters into exclusive agreement with HRA Pharma over Ulipristal, uterine fibroids drug
Shinpoong Pharmaceutical said on December 2 that it has signed an exclusive licensing agreement with France based HRA Pharma to develop and commercialize ulipristal acetate in Korea for benign gynecological disorders,...
Ildong to join hands with Taiwan Liposome Company
Ildong Pharmaceutical plans to commercialize ProFlow Injection (prostaglandin E1) in Korea through an exclusive distribution with Taiwan based Taiwan Liposome Company (TLC).
Ildong forecasts that TLC’s ProFlow will...
Recall of diet pill ‘sibutramine’ goes heeded
With the Korea Food and Drug Administration (KFDA)’s decision to ban sales of controversial sibutramine-based drugs, mostly used for weight loss last October, it is known that such drugs have been recalled properly du...
CKD Bio receives export award
CKD Bio, an affiliated company of Chong Kun Dang Pharmaceutical Co., was awarded the $100 million Export Tower by the Korea International Trade Association at the 47th Trade Day event on November 30.
The award was ...
